METROPOLITAN LIFE INSURANCE CO/NY - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$468,124
+77.6%
24,821
+10.8%
0.01%
+100.0%
Q2 2019$263,612
-5.3%
22,397
+9.8%
0.00%
-20.0%
Q1 2019$278,378
+26.2%
20,394
-5.2%
0.01%
+25.0%
Q4 2018$220,549
-38.4%
21,5170.0%0.00%
-33.3%
Q3 2018$358,258
-99.9%
21,5170.0%0.01%0.0%
Q2 2018$339,968,000
+24.4%
21,5170.0%0.01%
+50.0%
Q1 2018$273,266,000
+119230.1%
21,517
+7.8%
0.00%
+33.3%
Q4 2017$229,000
-57.7%
19,957
-54.9%
0.00%0.0%
Q3 2017$542,000
+42.6%
44,246
+33.4%
0.00%0.0%
Q2 2017$380,000
-44.9%
33,1640.0%0.00%
-40.0%
Q1 2017$690,000
-3.6%
33,164
-3.6%
0.01%0.0%
Q4 2016$716,000
-36.5%
34,4130.0%0.01%
-37.5%
Q3 2016$1,128,000
+31.3%
34,4130.0%0.01%
+33.3%
Q2 2016$859,000
+112.1%
34,413
+108.3%
0.01%
+100.0%
Q1 2016$405,000
-25.8%
16,5230.0%0.00%
-25.0%
Q4 2015$546,000
+0.9%
16,5230.0%0.00%0.0%
Q3 2015$541,000
-29.8%
16,523
+13.5%
0.00%
-20.0%
Q2 2015$771,000
+283.6%
14,561
+110.7%
0.01%
+400.0%
Q4 2014$201,0006,9110.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,628,328$33,869,00014.72%
Foresite Capital Management II, LLC 995,396$20,704,00010.39%
Cormorant Asset Management, LP 1,581,604$32,897,0004.43%
DAFNA Capital Management LLC 221,013$4,597,0004.04%
New Leaf Venture Partners, L.L.C. 228,428$4,751,0003.40%
Partner Investment Management, L.P. 63,571$1,322,0001.75%
Iguana Healthcare Management, LLC 140,000$2,912,0001.74%
PFM Health Sciences, LP 2,913,951$60,610,0001.71%
Redmile Group, LLC 920,550$19,147,0001.65%
SECTORAL ASSET MANAGEMENT INC 669,351$13,923,0001.54%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders